BURLINGTON, N.C., Sept. 14,
2023 /PRNewswire/ -- Labcorp (NYSE: LH), a
global leader of innovative and comprehensive laboratory services,
is hosting an Investor Day beginning at 1:00
p.m. ET today in New York
City, expected to conclude by approximately 4:00 p.m. ET. The event will highlight the
company's go-forward strategy from Labcorp Chairman & CEO
Adam Schechter, followed by business
overviews and a longer-term financial outlook by members of the
leadership team.
"Labcorp is the world's largest laboratory service provider
focused on science, technology and innovation," said Adam Schechter, chairman and CEO of Labcorp.
"Today, we are excited to share our roadmap for strong growth and
shareholder value across Diagnostics Laboratories and Biopharma
Laboratory Services. We believe that our focus on customers and our
ability to execute with scale and operational excellence will drive
strong profitable growth and further differentiate Labcorp."
Webcast Information
A live webcast of the event will
be available through the Labcorp Investor Relations website
beginning at 1:00 p.m. ET. A replay
of the webcast and a copy of presentation materials will be
available on the Investor Relations section of the Company's
website at https://ir.labcorp.com.
About Labcorp
Labcorp (NYSE: LH) is a global
leader of innovative and comprehensive laboratory services that
helps doctors, hospitals, pharmaceutical companies, researchers and
patients make clear and confident decisions. We provide insights
and advance science to improve health and improve lives through our
unparalleled diagnostics and drug development laboratory
capabilities. The company's more than 60,000 employees serve
clients in over 100 countries, worked on over 80% of the new drugs
approved by the FDA in 2022 and performed more than 600 million
tests for patients around the world. Learn more about us
at www.Labcorp.com.
Cautionary Statement Regarding Forward-Looking
Statements
This press release contains forward-looking
statements, including but not limited to statements with respect to
the company's expectations and opportunities for future
growth.
Each of the forward-looking statements is subject to change
based on various important factors, many of which are beyond the
company's control. These factors, in some cases, have affected and
in the future (together with other factors) could affect the
company's ability to implement the company's business strategy and
actual results could differ materially from those suggested by
these forward-looking statements. As a result, readers are
cautioned not to place undue reliance on any of the forward-looking
statements.
The company has no obligation to provide any updates to these
forward-looking statements even if its expectations change. All
forward-looking statements are expressly qualified in their
entirety by this cautionary statement. Further information on
potential factors, risks and uncertainties that could affect
operating and financial results is included in the company's most
recent Annual Report on Form 10-K and subsequent Forms 10-Q,
including in each case under the heading RISK FACTORS, and in the
company's other filings with the SEC. The information in this press
release should be read in conjunction with a review of the
company's filings with the SEC including the information in the
company's most recent Annual Report on Form 10-K, and subsequent
Forms 10-Q, under the heading MANAGEMENT'S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/labcorp-to-present-strategy-business-and-financial-outlook-at-investor-day-301927692.html
SOURCE Labcorp